Stocks News

LAST PRICE
162.8300
TODAY'S CHANGE (%)
Trending Down-0.7900 (-0.4828%)

Bid / Lots
156.8400/ 1
Ask / Lots
174.3600/ 1
Open / Previous Close
163.9200 / 163.6200
Day Range
Low 162.6700
High 167.1200
52 Week Range
Low 93.9500
High 189.9700
Volume
144,963
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 23, 2024
- Krystal Biotech Insider Sold Shares Worth $3,282,690, According to a Recent SEC Filing, from 3:49AM ET on Thursday May 23, 2024 by MT Newswires
  3:49AM ET on Thursday May 23, 2024 by MT Newswires
  Companies Mentioned: KRYS
  03:49 AM EDT, 05/23/2024 (MT Newswires) -- Julian S Gangolli, Director, on May 20, 2024, sold 20,000 shares in Krystal Biotech (KRYS) for $3,282,690. SEC Filing: https://www.sec.gov/Archives/edgar/data/1711279/000153202324000008/xslF345X03/wk-form4...
May 22, 2024
- DJ Krystal Biotech Currently Up Eight Consecutive Days, on Pace for Longest Winning Streak Since June 2018 -- Data Talk, from 11:49AM ET on Wednesday May 22, 2024 by Dow Jones
  11:49AM ET on Wednesday May 22, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Krystal Biotech, Inc. (KRYS) is currently at $172.22, up $5.39 or 3.23%
  
  --Would be highest close since April 12, 2024, when it closed at $173.62
  
  --On pace for largest percent increase since May 1, 2024, when it rose 4.28%
May 15, 2024
- Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  Companies Mentioned: KRYS
- Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by Dow Jones
  7:00AM ET on Wednesday May 15, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
  
  PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new preclinical data on respiratory genetic medicine candidates KB407 and KB408 at the American Thoracic Society (ATS) 2024 International Conference being held from May 17-22, 2024 in San Diego, California.
May 8, 2024
- DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 11:57AM ET on Wednesday May 08, 2024 by Dow Jones
  11:57AM ET on Wednesday May 08, 2024 by Dow Jones
  Companies Mentioned: KRYS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/KRYS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 08, 2024 11:57 ET (15:57 GMT)

May 24, 2024
- Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating, from 11:25AM ET on Friday May 24, 2024 by MT Newswires
  11:25AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: ALVO
May 22, 2024
- Update: Alvotech Narrows Q1 Loss as Revenue Increases; Shares Head Higher Premarket, from 5:49AM ET on Wednesday May 22, 2024 by MT Newswires
  5:49AM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: ALVO
- Alvotech Narrows Q1 Loss as Revenue Increases, from 5:05AM ET on Wednesday May 22, 2024 by MT Newswires
  5:05AM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: ALVO
May 21, 2024
- Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update, from 5:15PM ET on Tuesday May 21, 2024 by GlobeNewswire
  5:15PM ET on Tuesday May 21, 2024 by GlobeNewswire
  Companies Mentioned: ALVO
- Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia(R) & Xgeva(R) in the U.S., Europe and UK, from 10:05AM ET on Tuesday May 21, 2024 by Business Wire
  10:05AM ET on Tuesday May 21, 2024 by Business Wire
  Companies Mentioned: ALVO
- Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab, from 9:20AM ET on Tuesday May 21, 2024 by MT Newswires
  9:20AM ET on Tuesday May 21, 2024 by MT Newswires
  Companies Mentioned: RDY, ALVO
- Alvotech and Dr. Reddy's enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia(R) & Xgeva(R) in the U.S., Europe and UK, from 8:00AM ET on Tuesday May 21, 2024 by GlobeNewswire
  8:00AM ET on Tuesday May 21, 2024 by GlobeNewswire
  Companies Mentioned: ALVO
May 20, 2024
- Teva and Alvotech Announce SIMLANDI(R) (adalimumab-ryvk) Injection Now Available in the U.S., from 8:25PM ET on Monday May 20, 2024 by GlobeNewswire
  8:25PM ET on Monday May 20, 2024 by GlobeNewswire
  Companies Mentioned: TEVJF, ALVO
- Teva and Alvotech Announce SIMLANDI(R) (adalimumab-ryvk) Injection Now Available in the U.S., from 8:25PM ET on Monday May 20, 2024 by Business Wire
  8:25PM ET on Monday May 20, 2024 by Business Wire
  Companies Mentioned: TEVJF, ALVO
May 17, 2024
- Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing, from 4:48PM ET on Friday May 17, 2024 by MT Newswires
  4:48PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: NUVL

Krystal Biotech Inc
NASDAQ:KRYSUnited States

Search Criteria

May 23, 2024

Krystal Biotech Insider Sold Shares Worth $3,282,690, According to a Recent SEC Filing, from 3:49AM ET on Thursday May 23, 2024 by MT Newswires

May 22, 2024

DJ Krystal Biotech Currently Up Eight Consecutive Days, on Pace for Longest Winning Streak Since June 2018 -- Data Talk, from 11:49AM ET on Wednesday May 22, 2024 by Dow Jones

May 15, 2024

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by Dow Jones

May 8, 2024

DJ Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co., from 11:57AM ET on Wednesday May 08, 2024 by Dow Jones

Peers Headlines

May 24, 2024

Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating, from 11:25AM ET on Friday May 24, 2024 by MT Newswires

May 22, 2024

Update: Alvotech Narrows Q1 Loss as Revenue Increases; Shares Head Higher Premarket, from 5:49AM ET on Wednesday May 22, 2024 by MT Newswires

Alvotech Narrows Q1 Loss as Revenue Increases, from 5:05AM ET on Wednesday May 22, 2024 by MT Newswires

May 21, 2024

Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update, from 5:15PM ET on Tuesday May 21, 2024 by GlobeNewswire

Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia(R) & Xgeva(R) in the U.S., Europe and UK, from 10:05AM ET on Tuesday May 21, 2024 by Business Wire

Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab, from 9:20AM ET on Tuesday May 21, 2024 by MT Newswires

Alvotech and Dr. Reddy's enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia(R) & Xgeva(R) in the U.S., Europe and UK, from 8:00AM ET on Tuesday May 21, 2024 by GlobeNewswire

May 20, 2024

Teva and Alvotech Announce SIMLANDI(R) (adalimumab-ryvk) Injection Now Available in the U.S., from 8:25PM ET on Monday May 20, 2024 by GlobeNewswire

Teva and Alvotech Announce SIMLANDI(R) (adalimumab-ryvk) Injection Now Available in the U.S., from 8:25PM ET on Monday May 20, 2024 by Business Wire

May 17, 2024

Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing, from 4:48PM ET on Friday May 17, 2024 by MT Newswires